Beyond the Hype: Is Colonoscopy Efficiency the Key to Better Detection?
"A New Metric, SP6, Aims to Revolutionize Colonoscopy Assessment"
Colonoscopies are a cornerstone of bowel cancer screening, but ensuring their effectiveness and efficiency is an ongoing challenge. While Adenoma Detection Rate (ADR) has been a key metric, it doesn't fully capture the nuances of polyp detection, particularly sessile serrated polyps/adenomas (SSP/A) which can be easily missed.
A recent study has introduced a new measure of colonoscopy efficiency called SP6 (Significant Polyps detected per 6 minutes of withdrawal time). This metric aims to provide a more comprehensive assessment of colonoscopy quality by evaluating the number of significant polyps detected relative to the time spent during the procedure.
This article explores the SP6 metric, its potential benefits for improving colonoscopy performance, and how it compares to traditional measures like ADR. We'll delve into how SP6 might revolutionize colonoscopy assessment and contribute to better patient outcomes.
Detection and the Role of Colonoscopy
Colonoscopy is described as the gold-standard tool for colorectal cancer detection because it allows polyps to be identified and removed during the procedure; removed polyps can then undergo histological analysis to assess malignancy. Careful, systematic inspection of the colonic lining and removal of precancerous polyps are central goals of screening. A 2025 real-world study proposal notes a lack of data on surgeons’ use of Endocuff and sets out to compare Endocuff-assisted colonoscopy with standard colonoscopy for polyp detection rate and estimated adenoma detection rate.
Colonoscopy as the Standard
Colonoscopy with polypectomy remains the gold-standard investigation for detecting and preventing colorectal cancer. Its preventive value depends on finding precancerous lesions and removing them, interrupting the progression from adenoma to carcinoma. Computer-aided detection systems have been introduced to help clinicians spot polyps more consistently, with reviews assessing their effects on detection and missed lesions as well as the challenge of relying on AI alongside human skill. A survey of polyp-detection methods also covers benchmark datasets, evaluation metrics, and common technical challenges.
SP6: A New Lens for Evaluating Colonoscopy Performance
The SP6 metric offers a fresh perspective by considering both adenoma and SSP/A detection in relation to withdrawal time. This is crucial because SSP/As, often subtle and difficult to spot, have a significant potential for malignant transformation. Unlike ADR, SP6 incentivizes thorough examination and detection of all precancerous lesions.
- Enhanced Lesion Detection: SP6 promotes the detection of both adenomas and SSP/As, leading to a more comprehensive assessment of colonoscopy quality.
- Time Efficiency: By factoring in withdrawal time, SP6 encourages endoscopists to perform thorough examinations without sacrificing speed.
- Technology Assessment: SP6 can be used to evaluate the effectiveness of different colonoscopy techniques and technologies, such as Endocuff-assisted colonoscopy.
- Quality Benchmark: An SP6 >1 can be achieved in bowel cancer screening (FOBT positive colonoscopy) and may act as a new benchmark to demonstrate high quality examinations.
New Reviews of Detection and AI
Recent reviews examine advances in colonoscopy detection techniques, the evidence behind benchmark quality metrics, and approaches intended to improve performance and reduce colorectal cancer incidence. A 2026 review of AI in colonoscopy imaging summarizes deep-learning advances and identifies future research directions for polyp detection, diagnosis, and clinical decision-making. A June 2026 review notes that earlier systematic reviews often analyzed computer-aided detection systems as a single intervention. A separate 2026 systematic review and meta-analysis evaluates randomized trials of AI-assisted colonoscopy using adenoma detection rate and polyp detection rate as outcomes.
Real-World Questions for CADe
A retrospective study from Poland evaluated endoscopists’ adenoma detection rates during the three months before and after computer-aided detection was introduced in their endoscopy suites. The provided account identifies the study design and comparison period but does not report the results, so it does not establish whether detection improved. A 2026 narrative review describes AI-powered CADe as promising while also reviewing its clinical efficacy, limitations, and future directions.
Standard Colonoscopy and AI Assistance
Colonoscopy uses a flexible camera-equipped tube to inspect the large intestine and rectum for abnormalities, including polyps and signs of cancer. Adenoma detection rate is identified as a major quality indicator, and one cited cohort followed more than 45,000 colonoscopies performed by 186 endoscopists; it recorded 42 interval cancers over 188,788 person-years. Real-time computer-aided polyp detection has shown high accuracy in artificial settings, while preliminary randomized controlled trials have reported favorable outcomes. The supplied source material does not provide comparative effect sizes, so it does not quantify how much AI changes detection relative to standard colonoscopy.
The Future of Colonoscopy: Prioritizing Efficiency and Thoroughness
The introduction of the SP6 metric highlights a growing recognition of the need for more refined measures of colonoscopy quality. While ADR remains a valuable indicator, SP6 offers a complementary perspective by emphasizing the importance of both lesion detection and time efficiency.
Training and System-Level Barriers
A 2026 training study reports that experts achieved higher polyp-detection and cecal-intubation rates than residents. It identifies navigation, scope manipulation, and inspection behind folds as challenges residents face, contrasting these with expert strategies. An American Gastroenterological Association white paper based on a conference of more than 60 colorectal cancer experts considers screening uptake, polyp detection, persistent barriers to colonoscopy use, and opportunities for performance improvement and innovation. A 2019 review also discusses challenges in colorectal cancer screening and training programs, colonoscopy quality measures, and convolutional neural networks for detecting polyps and early cancerous lesions.
As healthcare systems worldwide strive to improve cancer screening programs, metrics like SP6 can play a vital role in optimizing colonoscopy performance and ensuring that patients receive the most effective and thorough examinations possible.
Further research is needed to validate the SP6 metric and establish its widespread adoption. However, its potential to enhance colonoscopy efficiency and improve bowel cancer screening outcomes makes it a promising development in the field of gastroenterology.